I have just read an interesting article on www.firstwordpluss.com that I wanted to share with you.
“The pharmaceutical industry agreed to a proposal to provide drug discounts to US Medicare beneficiaries that could be worth up to $80 billion over the next ten years. The proposal, which is part of a health-care bill drafted by US lawmakers on June 19, aims to reduce the coverage gap that affects recipients once their drug costs reach a certain level”
Its part of the sign that the USA is moving away from being the golden goose drug market that many have known for years and is moving to a more European model for health markets, this was inevitable and matches some of the predictions previously published on this site (see here). Its inevitable that as health care budgets become a larger part of national spending this kind of trend is only going to become more apparent.
More on the article
“As part of the deal that was negotiated between PhRMA and lawmakers, drugmakers would “provide a 50-percent discount to most beneficiaries on brand-name medicines covered by a patient’s Part D plan when purchased in the coverage gap,” according to industry representatives. In addition, the entire cost of the medicine purchased in the coverage gap will count towards the Medicare recipient’s out-of-pocket expenses.”
If you would like more detail in this area please get in touch with Damien Bové damien.bove@idaconsultants.com
Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.
Grow your Expertise for Free
As you know this website is a great resource for keeping up to date with developments and regulations, why not get our FREE monthly regulatory and market round up. You can un-subscribe at any time and we do not share your details with anybody.
